AJP - Heart and Circulatory Physiology, Vol 252, Issue 4 796-H806, Copyright © 1987 by American Physiological Society

ARTICLES

Sympathetic function in spontaneously hypertensive rats after chronic administration of captopril

K. H. Berecek, K. A. Kirk, S. Nagahama and S. Oparil

The cardiovascular effects of electrical stimulation of the posterior hypothalamus, intravenous administration of norepinephrine (NE), and direct sympathetic nerve stimulation (SNS) were compared in spontaneously hypertensive (SHR) and Wistar-Kyoto rats (WKY) given captopril (osmotic minipump, 1.25 micrograms/h icv) or vehicle for 4 wk beginning at age 7 wk. Mean arterial pressure (MAP) and renal and mesenteric flows (pulsed Doppler flow probes) were monitored in anesthetized rats. Following chronic administration of captopril the MAP was 141 +/- 4 mmHg in SHR receiving captopril and 183 +/- 6 mmHg in SHR receiving vehicle. Posterior hypothalamic stimulation, intravenous NE, and SNS resulted in lesser increases in MAP and renal and mesenteric vascular resistances in SHR treated with captopril. Response curves were shifted to the right, and the initial slopes and rate of change of slopes of the curves were less in captopril-treated SHR than vehicle-treated rats. The decrease in sensitivity to posterior hypothalamic stimulation was greater than the decrease in response to NE or SNS. The decrease in vascular reactivity in captopril-treated SHR was not due to increased sensitivity of the baroreflex for control of vascular resistance nor to a decrease in arterial pressure per se. WKY treated with captopril also showed lesser increases in MAP and renal and mesenteric vascular resistances in response to posterior hypothalamic stimulation, intravenous NE, and SNS. The depressor effects of intracerebroventricular captopril in SHR may be due, in part, to an attenuation in sympathetic vasoconstrictor tone. This attenuation involves both a decrease in vascular smooth muscle responsiveness to NE as well as a decrease in central stimulation of sympathetic outflow.

This article has been cited by other articles:

				C. T. Sangaleti, A. Crescenzi, and L. C. Michelini Endogenous Angiotensin and Pressure Modulate Brain Angiotensinogen and AT1A mRNA Expression Hypertension, February 1, 2004; 43(2): 317 - 323. [Abstract] [Full Text] [PDF]

				H. E. De Wardener The Hypothalamus and Hypertension Physiol Rev, October 1, 2001; 81(4): 1599 - 1658. [Abstract] [Full Text] [PDF]

				S. M.M.S. Bezerra, C. M. dos Santos, E. D. Moreira, E. M. Krieger, and L. C. Michelini Chronic AT1 Receptor Blockade Alters Autonomic Balance and Sympathetic Responses in Hypertension Hypertension, September 1, 2001; 38(3): 569 - 575. [Abstract] [Full Text] [PDF]

				J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]

				J. P. Collister and J. W. Osborn Area postrema lesion attenuates the long-term hypotensive effects of losartan in salt-replete rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R357 - R366. [Abstract] [Full Text] [PDF]

				J. P. Collister, B. J. Hornfeldt, and J. W. Osborn Hypotensive Response to Losartan in Normal Rats : Role of Ang II and the Area Postrema Hypertension, March 1, 1996; 27(3): 598 - 606. [Abstract] [Full Text]

				C.-T. Ting, C.-H. Chen, M.-S. Chang, and F. C.P. Yin Short- and Long-term Effects of Antihypertensive Drugs on Arterial Reflections, Compliance, and Impedance Hypertension, September 1, 1995; 26(3): 524 - 530. [Abstract] [Full Text]

				C.-T. Ting, J.-W. Chen, M.-S. Chang, and F. C. P. Yin Arterial Hemodynamics in Human Hypertension : Effects of the Calcium Channel Antagonist Nifedipine Hypertension, June 1, 1995; 25(6): 1326 - 1332. [Abstract] [Full Text]

				D. Wielbo, C. Sernia, R. Gyurko, and M. I. Phillips Antisense Inhibition of Hypertension in the Spontaneously Hypertensive Rat Hypertension, March 1, 1995; 25(3): 314 - 319. [Abstract] [Full Text]